{"name":"InVasc Therapeutics, Inc.","slug":"invasc-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"immunology","drugs":[{"name":"amlodipine and olmesartan","genericName":"amlodipine and olmesartan","slug":"amlodipine-and-olmesartan","indication":"Hypertension","status":"marketed"},{"name":"losartan and HCTZ","genericName":"losartan and HCTZ","slug":"losartan-and-hctz","indication":"Hypertension","status":"marketed"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"accupril, alpha lipoic acid","genericName":"accupril, alpha lipoic acid","slug":"accupril-alpha-lipoic-acid","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"accupril, alpha lipoic acid","genericName":"accupril, alpha lipoic acid","slug":"accupril-alpha-lipoic-acid","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"amlodipine and olmesartan","genericName":"amlodipine and olmesartan","slug":"amlodipine-and-olmesartan","phase":"marketed","mechanism":"Small molecule","indications":["Hypertension","Initial Therapy for Hypertension"],"catalyst":""},{"name":"losartan and HCTZ","genericName":"losartan and HCTZ","slug":"losartan-and-hctz","phase":"marketed","mechanism":"Losartan blocks angiotensin II receptors to relax blood vessels, while HCTZ increases sodium and water excretion to reduce blood volume, together lowering blood pressure.","indications":["Hypertension","Reduction of cardiovascular risk in hypertensive patients"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiaEFVX3lxTE5Qc3AyUkJfeXFtQUY2UUcyQ3p4NE9pczA0QmJwV2prTUNlWEtXRF81WkZNNnR3MzM0MFdDRmNIVHpqTUxZVlc2VTl5aWcyVy1CQ3lyOE5NNE8zTUl3clJzTFd5a2VnN2Zs?oc=5","date":"2012-05-15","type":"pipeline","source":"Genetic Engineering and Biotechnology News","summary":"People in the News - Genetic Engineering and Biotechnology News","headline":"People in the News","sentiment":"neutral"}],"patents":[],"drugCount":3,"phaseCounts":{"phase_1":1,"marketed":2},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}